Granules India Limited

NSE GRANULES.NS

Granules India Limited Net Cash Used For Investing Activities for the year ending March 31, 2024: USD -43.18 M

Granules India Limited Net Cash Used For Investing Activities is USD -43.18 M for the year ending March 31, 2024, a -267.95% change year over year. Net cash used for investing activities is total cash inflows and outflows related to activities intended to generate future income and cash flows from investments.
  • Granules India Limited Net Cash Used For Investing Activities for the year ending March 31, 2023 was USD -11.74 M, a 76.56% change year over year.
  • Granules India Limited Net Cash Used For Investing Activities for the year ending March 31, 2022 was USD -50.06 M, a -32.27% change year over year.
  • Granules India Limited Net Cash Used For Investing Activities for the year ending March 31, 2021 was USD -37.85 M, a -77.56% change year over year.
  • Granules India Limited Net Cash Used For Investing Activities for the year ending March 31, 2020 was USD -21.32 M, a 45.10% change year over year.
Key data
Date Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities Dividends Paid Capital Expenditure
Market news
Loading...
SV Wall Street
NSE: GRANULES.NS

Granules India Limited

CEO Dr. Kandiraju Venkata Sita Ram Rao B.Tech, M.E., Ph.D.
IPO Date June 20, 2005
Location India
Headquarters My Home Hub
Employees 4,057
Sector Health Care
Industries
Description

Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India, North America, Europe, Latin America, Africa, the Middle East, and internationally. The company's APIs in various therapeutic categories include anti-retrovirals, anti-hypertensives, anti-histamines, anti-infectives, analgesics, anti-coagulants, anti-fibriotics, and platelet inhibitors. It also offers various FDs, such as tablets, caplets, and press-fit capsules in bulk, blister packs, and bottles; and other specialty products for oncology. The Company also exports its products. Granules India Limited was founded in 1984 and is based in Hyderabad, India.

Similar companies

IPCALAB.NS

Ipca Laboratories Limited

USD 16.64

-0.86%

AUROPHARMA.NS

Aurobindo Pharma Limited

USD 13.51

-1.02%

APLLTD.NS

Alembic Pharmaceuticals Limited

USD 10.61

0.92%

LAURUSLABS.NS

Laurus Labs Limited

USD 6.73

-0.82%

GLENMARK.NS

Glenmark Pharmaceuticals Limited

USD 16.75

0.23%

StockViz Staff

February 1, 2025

Any question? Send us an email